Sign in
4

Changes in Ownership

ImmunityBio, Inc. Filed Acc 0001326110-23-000092

Chief Accounting Officer acquired 21,030 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LAUER REGAN J · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-15 Exercise or conversion : show line 1 in the form +21,030 21,030 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-06-15 Exercise or conversion : show line 2 in the form Restricted Stock Units −21,030 42,061 D
Loading xslF345X04/wk-form4_1686951925.xml…